Aylin Riedel

1.4k total citations
28 papers, 1.1k citations indexed

About

Aylin Riedel is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Nephrology. According to data from OpenAlex, Aylin Riedel has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 5 papers in Nephrology. Recurrent topics in Aylin Riedel's work include Asthma and respiratory diseases (8 papers), Respiratory and Cough-Related Research (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Aylin Riedel is often cited by papers focused on Asthma and respiratory diseases (8 papers), Respiratory and Cough-Related Research (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Aylin Riedel collaborates with scholars based in United States, India and Canada. Aylin Riedel's co-authors include Katrine L. Wallace, Nancy Joseph‐Ridge, Robert L. Wortmann, Craig Plauschinat, Michael A. Becker, Jenifer Wogen, Patricia MacDonald, Herbert C. Heien, Michael A. Nelson and Anne C. Petersen and has published in prestigious journals such as Circulation, Journal of Allergy and Clinical Immunology and Clinical Therapeutics.

In The Last Decade

Aylin Riedel

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aylin Riedel United States 14 537 354 332 141 135 28 1.1k
O E Ayodele Nigeria 21 501 0.9× 97 0.3× 131 0.4× 199 1.4× 28 0.2× 59 1.3k
Ryuichi Kawamoto Japan 20 277 0.5× 128 0.4× 94 0.3× 134 1.0× 173 1.3× 59 1.1k
F Álvarez-Ude Spain 21 650 1.2× 176 0.5× 51 0.2× 96 0.7× 110 0.8× 73 1.2k
Kraig Kinchen United States 18 285 0.5× 441 1.2× 802 2.4× 188 1.3× 38 0.3× 34 1.6k
Marc H. Hemmelder Netherlands 19 532 1.0× 104 0.3× 38 0.1× 132 0.9× 45 0.3× 71 1.2k
Evi Nagler Belgium 14 443 0.8× 337 1.0× 18 0.1× 74 0.5× 43 0.3× 33 1.3k
Adem Özkara Türkiye 11 248 0.5× 126 0.4× 44 0.1× 55 0.4× 153 1.1× 67 588
L Suarez United States 17 167 0.3× 99 0.3× 92 0.3× 190 1.3× 43 0.3× 24 1.4k
Onyekachi Ifudu United States 20 932 1.7× 162 0.5× 31 0.1× 54 0.4× 37 0.3× 50 1.4k
James E. Smeeding United States 15 210 0.4× 267 0.8× 121 0.4× 13 0.1× 54 0.4× 22 821

Countries citing papers authored by Aylin Riedel

Since Specialization
Citations

This map shows the geographic impact of Aylin Riedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aylin Riedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aylin Riedel more than expected).

Fields of papers citing papers by Aylin Riedel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aylin Riedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aylin Riedel. The network helps show where Aylin Riedel may publish in the future.

Co-authorship network of co-authors of Aylin Riedel

This figure shows the co-authorship network connecting the top 25 collaborators of Aylin Riedel. A scholar is included among the top collaborators of Aylin Riedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aylin Riedel. Aylin Riedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akazawa, Manabu, Christopher M. Blanchette, Aylin Riedel, et al.. (2021). Economic burden prior to COPD diagnosis: A matched case-control study in the United States. UNC Libraries.
2.
Swindle, Jason, Wing Chan, Katherine Waltman Johnson, et al.. (2013). Abstract 12097: Renal Impairment in Acute Heart Failure: Insights From a Managed Care Database. Circulation. 128. 1 indexed citations
3.
Garris, Cindy, Priti Jhingran, Damon Bass, et al.. (2013). Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan. Journal of Medical Economics. 16(5). 667–677. 85 indexed citations
4.
Stanford, Richard H., et al.. (2012). Asthma controller delay and recurrence risk after an emergency department visit or hospitalization. Respiratory Medicine. 106(12). 1631–1638. 9 indexed citations
5.
Wenten, Madé, et al.. (2011). PDB1 TREATMENT PATTERNS AND OUTCOMES AMONG OLDER EXENATIDE BID USERS COMPARED TO INSULIN GLARGINE USERS. Value in Health. 14(3). A91–A91. 1 indexed citations
6.
Dalal, Anand A., et al.. (2011). Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009. International Journal of COPD. 6. 533–533. 24 indexed citations
7.
Fuldeore, Mahesh, Aylin Riedel, Victoria Zarotsky, et al.. (2011). Chronic kidney disease in gout in a managed care setting. BMC Nephrology. 12(1). 36–36. 37 indexed citations
8.
Pandya, Bhavik J., Aylin Riedel, Jason Swindle, et al.. (2011). Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings. Current Medical Research and Opinion. 27(4). 737–744. 16 indexed citations
9.
Lynch, Peter, et al.. (2010). Resource utilization with insulin pump therapy for type 2 diabetes mellitus.. PubMed. 16(12). 892–6. 17 indexed citations
10.
11.
Stanford, Richard H., Aylin Riedel, Jonathan Johnson, & Calvin L. Astry. (2010). Comparative resource utilization in medicaid-eligible patients with asthma treated with fixed-dose fluticasone propionate/salmeterol or fluticasone propionate monotherapy. Clinical Therapeutics. 32(10). 1782–1793. 2 indexed citations
12.
13.
Stanford, Richard H., et al.. (2008). An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes. Current Medical Research and Opinion. 24(11). 3141–3148. 13 indexed citations
14.
Akazawa, Manabu, Rachel Halpern, Aylin Riedel, et al.. (2008). Economic burden prior to COPD diagnosis: A matched case-control study in the United States. Respiratory Medicine. 102(12). 1744–1752. 45 indexed citations
15.
Schabert, Vernon F., Xin Ye, Ralph P. Insinga, Puneet K. Singhal, & Aylin Riedel. (2008). Five-year routine cervical cancer screening rates and intervals in a US health plan. Current Medical Research and Opinion. 24(9). 2429–2435. 13 indexed citations
16.
Riedel, Aylin, Herbert C. Heien, Jenifer Wogen, & Craig Plauschinat. (2007). Loss of Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Were Receiving Initial Metformin, Sulfonylurea, or Thiazolidinedione Monotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(8). 1102–1110. 71 indexed citations
17.
Stempel, David A., Aylin Riedel, & Jacqueline R. Carranza Rosenzweig. (2006). Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma. Current Medical Research and Opinion. 22(3). 463–470. 19 indexed citations
18.
Riedel, Aylin, et al.. (2004). Prevalence of Comorbid Conditions and Prescription Medication Use Among Patients With Gout and Hyperuricemia in a Managed Care Setting. JCR Journal of Clinical Rheumatology. 10(6). 308–314. 54 indexed citations
19.
Allen‐Ramey, Felicia, et al.. (2004). Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline. Annals of Allergy Asthma & Immunology. 93(4). 373–380. 8 indexed citations
20.
Call, Kathleen Thiede, Aylin Riedel, Karen Hein, et al.. (2002). Adolescent Health and Well‐Being in the Twenty‐First Century: A Global Perspective. Journal of Research on Adolescence. 12(1). 69–98. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O E Ayodele Breakdown of academic impact, for papers by Ryuichi Kawamoto Breakdown of academic impact, for papers by F Álvarez-Ude Breakdown of academic impact, for papers by Kraig Kinchen Breakdown of academic impact, for papers by Marc H. Hemmelder Breakdown of academic impact, for papers by Evi Nagler Breakdown of academic impact, for papers by Adem Özkara Breakdown of academic impact, for papers by L Suarez Breakdown of academic impact, for papers by Onyekachi Ifudu Breakdown of academic impact, for papers by James E. Smeeding
Rankless by CCL
2026